ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,459.10
1.11%
US Tech 100
18,522.40
1.05%
다우존스 지수
40,589.34
1.64%
Bitcoin
67,858.07
-0.08%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NYSE
  6. AbbVie Inc (ABBV)

  7. AbbVie Inc (ABBV) 뉴스

ABBV AbbVie Inc

185.00
2.83 (1.55%)
27 7월(7) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
AbbVie Inc ABBV NYSE 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
2.83 1.55% 185.00 09:00:00
개장가 저가 고가 종가 전일 종가
183.85 182.11 186.85 185.16 182.17
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
26/07/202415:00PRNUSAbbVie Announces European Commission Approval of SKYRIZI®..
25/07/202420:41EDGAR2Form 8-K - Current report
25/07/202420:36PRNUSAbbVie Reports Second-Quarter 2024 Financial Results
25/07/202419:21IHMARKETNEWSU.S. Index Futures Mixed After Tech Sell-Off, Oil Prices..
23/07/202420:02PRNCAAbbVie's EPKINLY™ Receives First-Ever Time-Limited..
12/07/202421:30PRNUSAbbVie Submits Regulatory Applications to FDA and EMA for..
10/07/202421:00PRNUSAbbVie Announces Appointment of Roopal Thakkar, M.D. as..
05/07/202421:13IHMARKETNEWSTesla Listed for China’s Government Vehicles; Macy’s..
02/07/202421:00PRNUSAbbVie to Host Second-Quarter 2024 Earnings Conference Call
01/07/202421:00PRNUSRobert A. Michael Assumes Role as AbbVie Chief Executive..
28/06/202415:00PRNUSAbbVie Receives Positive CHMP Opinion for Epcoritamab..
27/06/202422:26PRNUSAbbVie Acquires Celsius Therapeutics
27/06/202421:30PRNUSIntroducing Allē Payment Plans, Powered by Cherry
27/06/202408:03PRNUSU.S. Food and Drug Administration Grants Second Approval for..
25/06/202421:15PRNUSAbbVie Provides U.S. Regulatory Update on ABBV-951..
21/06/202421:00PRNUSAbbVie Declares Quarterly Dividend
20/06/202421:00PRNUSAbbVie Appoints Roxanne S. Austin as Lead Independent..
19/06/202407:18PRNUSU.S. FDA Approves SKYRIZI® (risankizumab-rzaa) for..
15/06/202405:08PRNUSAbbVie Recommends Shareholders Reject Tutanota's..
13/06/202420:59PRNUSAbbVie and FutureGen Announce License Agreement to Develop..
11/06/202421:00PRNUSBOTOX® Cosmetic (onabotulinumtoxinA) Reveals 2024 Women..
06/06/202421:45PRNUSAbbVie Announces Positive Topline Results from Phase 2..
06/06/202421:30PRNUSSkinMedica® Celebrates 25 Years of Empowering Radiant Skin
06/06/202421:00PRNUSAbbVie Launches First-of-its-Kind Contest to Empower People..
05/06/202422:00PRNUSAbbVie Advances Oncology Pipeline With Start of Multiple..
04/06/202421:30PRNUSRINVOQ® (upadacitinib) Now Available for Pediatric Patients..
04/06/202421:05PRNUSRefer Your Friends to Allē, the Loyalty Rewards Program by..
03/06/202421:30PRNUSAbbVie to Present at the Goldman Sachs 45th Annual Global..
01/06/202405:05EDGAR2Form SD - Specialized disclosure report
31/05/202415:00PRNUSAbbVie Receives Positive CHMP Opinion for Risankizumab..
28/05/202421:00PRNUSAbbVie Showcases Robust Solid Tumor Pipeline at ASCO 2024..
24/05/202405:05PRNUSAbbVie Completes Acquisition of Landos Biopharma
17/05/202420:30PRNUSAbbVie Presents New Data Supporting Leading Gastroenterology..
13/05/202421:39PRNUSAbbVie and Gilgamesh Pharmaceuticals Announce Collaboration..
09/05/202406:00EDGAR2Form 8-K/A - Current report: [Amend]
08/05/202421:00PRNCAQULIPTA™ (atogepant) Now Approved by Health Canada for the..
08/05/202409:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/05/202407:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/05/202407:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/05/202407:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/05/202421:00PRNUSAbbVie to Present at the Bank of America Securities..
26/04/202420:47IHMARKETNEWSU.S. Futures Climb in Pre-Market Trading Amid Tech Gains and..
26/04/202420:35PRNUSAbbVie Reports First-Quarter 2024 Financial Results
25/04/202421:00PRNUSNew Data Show RINVOQ® (upadacitinib) Demonstrated..
23/04/202421:00PRNUSAllergan Aesthetics Invites Consumers to Be the Face of..
18/04/202421:31PRNUSPhase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed..
12/04/202420:30PRNUSAbbVie Announces Late-Breaking Data at AAN Supporting..
09/04/202421:00PRNUSSkinMedica® Empowers Clear Skin Confidence with a New,..
04/04/202421:00PRNUSAbbVie to Host First-Quarter 2024 Earnings Conference Call
03/04/202421:30PRNUSAllergan Aesthetics Announces the Return of CoolMonth with..

최근 히스토리

NYSE
ABBV
AbbVie
EU
FER
Ferrovial
BIT
P15Y74
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유